In the News Archive

  • NYTimes Letter to the Editor: Drug Shortages Continue to Vex Doctors
    February 11, 2014 | New York Times 
  • Outlook 2014: Capitol Commotion
    December 1, 2013 | Medical Marketing and Media 
  • States copying market-based Medicare plan
  • August 14, 2013 | The Philadelphia Inquirer 
  • Medicare Budget Cuts Could Threaten Cancer Patients' Access To Drug Treatments
    August 2, 2013 | Forbes 
  • Government must avoid change in Medicare Part D
    July 1, 2013 | Sun Sentinel 
  • The Wrong Way to Dispose of Drugs
    May 24, 2013 | The Huffington Post 
  • A Hammer in Search of a Nail
    May 24, 2013 | The Burrill Report 
  • A common-sense cut to health care spending
    May 6, 2013 | AL 
  • When generics win, patients lose
    May 1, 2013 | Washington Times 
  • Liberals still going after Medicare drug benefit
    April 8, 2013 | Sun Sentinel 
  • Novartis verdict fallout: Patents vs patients?
    April 6, 2013 | NDTV 
  • Indian drugs will now face backlash, warn analysts in US after Novartis ruling
    April 3, 2013 | NDTV 
  • Obama's fiscal cliff drug 'reform' idea will backfire
  • December 20, 2012 | The Washington Examiner 
  • Experts stress need for innovation in healthcare
    November 28, 2012 | Gulf News 
  • Mirror, Mirror
    November 16, 2012 | The Burrill Report 
  • Biosimilars: The Precarious Struggle Between Cost-driven Health Care Policy and Patient-centered Care
    September 30, 2012 | Washington Policy Center
  • An Ugly Way To Get Insurance
    September 19, 2012 | New York Post
  • Measuring Responsibility in Big Pharma
    September 7, 2012 | Pharmaceutical Executive
  • Protecting Sustainable Innovation
    August 31, 2012 | The Burrill Report
  • The Evolution of Health Care
  • June 29, 2012 | The Chicago Tribune
  • Two ideas on how to save Medicare
  • June 19, 2012 | Washington Examiner
  • Contraception, who cares?
    June 18, 2012 | MedAd News
  • A Gentleman’s D for Mitt
    June 15, 2012 | The Burrill Report
  • Da Bomb
    June 7, 2012 | The Burrill Report
  • Getting Back on Track (and Trace)
    June 1, 2012 | The Burrill Report
  • Living in a Post-IPAB World
    May 30, 2012 | The Riverdale Press
  • Another deadly taste of ObamaCare
    May 29, 2012 | New York Post
  • Animal health and human health are inextricably linked
  • May 15, 2012 | The Hill
  • Drug Shortages and the Role of the Middle Man
    April 13, 2012 | The Burrill Report
  • Obamacare's Medical Mercenaries
    April 13, 2012 | The American Spectator
  • Positive Signals from Washington
    April 13, 2012 | Nature Biotechnology
  • Affordable Care Act Isn't
    April 7, 2012 | The Boston Herald
  • Obama's Broken Promise to Wounded Warriors
    March 27, 2012 | The American Spectator
  • Drugs of Choice
    March 23, 2012 | The Washington Times
  • Sunday Dialogue: Equitable Health Care
    March 23, 2012 | New York Times
  • Time to bid adieu to Obamacare's IPAB
    March 15, 2012 | The Washington Examiner
  • Joint Custody
    March 2, 2012 | The Burrill Report
  • Republicans Rock the Airwaves
    February 24, 2012 | The American Spectator
  • Obama's Nurse Ratched
    February 16, 2012 | The American Spectator
  • Cancer Patients Fume Over Counterfeit Avastin
  • February 15, 2012 | ABC News
  • America needs more breakthrough 'progressive' medicines
    February 14, 2012 | The Washington Examiner
  • The Sinews of Safety
    February 9, 2012 | The Burrill Report
  • Drug Supplies and Economics 101
    February 3, 2012 | The Burrill Report
  • Cutting Healthcare Spending with Occam's Razor
    January 13, 2012 | The Burrill Report
  • May 2009 | Nature Biotechnology
  • FDA On Warpath For Google Links
    May 2009 | Nature Biotechnology
Sign Up for Our Email Newsletter

RECENT NEWS

Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent

Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent

Waiving patent protection discourages cutting-edge research investments, which in turn produce breakthrough treatments no...  Read more

'I'm hopeful for the future': Alzheimer's drug approved by FDA

'I'm hopeful for the future': Alzheimer's drug approved by FDA

Peter Pitts of CMPI and Dr. Ronald Petersen of the Mayo Clinic discuss the FDA's approval of aducanumab...  Read more

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilars bring lower costs and greater access to the market for biological products, but FDA must determine a predicta...  Read more

DRUGWONKS BLOG